John Lewis

Co-Founder & CEO at Aegis BioDefense Inc., USA

Speaker

Dr. John Lewis is CEO of Aegis BioDefense, a biotechnology company developing genetic vaccines and therapeutics for infectious diseases using the Fusogenix drug delivery system. Dr. Lewis is also the co-founder of OncoSenX and heads its cancer-fighting platform technology development and CEO of Nanostics, a company that develops and commercializes novel, non-invasive cancer diagnostic tests. Dr. Lewis holds the Frank and Carla Sojonky Chair in Prostate Cancer Research and is a Professor in the Department of Oncology, where he chairs the Alberta Prostate Cancer Research Initiative.